November 21, 2024

Phase 3 win for Protagonist Therapeutics with oral plaque psoriasis drug – OutSourcing-Pharma.com

November 20, 2024

Profiling CARD14 gene expression in Indian Psoriasis patients – Nature.com

November 20, 2024

Physician Views Preview — Will J&J’s icotrokinra set a new bar for oral psoriasis treatments? – FirstWord Pharma

November 20, 2024

New phase 3 data of JNJ-2113 for plaque psoriasis in patients aged 12 years, older – Contemporary Pediatrics

November 19, 2024

J&J plots filings after psoriasis drug clears phase 3 test – pharmaphorum